SEC Filing · 6-K
BioHarvest Sciences Inc.
BHSTNASDAQEQUITYCurrent
SEC Filing
Press release in this filing
TATE & LYLE AND BIOHARVEST REACH KEY MILESTONE IN NEXT-GENERATION SWEETENER DEVELOPMENT PROGRAMME →Company context
BioHarvest Sciences Inc. (Nasdaq: BHST) (TASE: BHST) (FSE: 8MV0) is a biotechnology company pioneering its proprietary Botanical Synthesis™ technology, an advanced plant-cell-based platform designed to produce valuable plant-derived compounds without growing and harvesting the complete source plant. The Company applies Botanical Synthesis™ across its proprietary asset portfolio and through its CDMO business to develop and manufacture high-value plant-derived compounds for customers and commercial partners. VINIA® represents BioHarvest’s first commercialized product and provides a demonstrated pathway from plant-cell development through manufacturing and commercialization. BioHarvest is applying that same platform to build a broader portfolio of proprietary and customer-sponsored assets across multiple high-value categories.